Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01729455
What this trial is testing

Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 3,138
Large-scale testing (Phase 3)Study completedNCT01484496
What this trial is testing

Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 839
Testing effectiveness (Phase 2)WithdrawnNCT05604742
What this trial is testing

Belimumab for Treatment of cGVHD Following Allo-HCT

Who this might be right for
cGVHD
xuna
Early research (Phase 1)Study completedNCT01583530
What this trial is testing

Study of Belimumab Administered Subcutaneously to Healthy Subjects

Who this might be right for
Healthy
Human Genome Sciences Inc. 118
Not applicableStudy completedNCT05624437
What this trial is testing

BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus

Who this might be right for
SLE (Systemic Lupus)
Centre Hospitalier de Niort 33
Not applicableUnknownNCT03919643
What this trial is testing

BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE

Who this might be right for
Systemic Lupus ErythematosusBAFF Polymorphism
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 200
Not applicableStudy completedNCT03154385
What this trial is testing

Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 15
Early research (Phase 1)Looking for participantsNCT06576271
What this trial is testing

GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 142
Not applicableStudy completedNCT07031674
What this trial is testing

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Who this might be right for
Lupus NephritisBelimumab
Yipeng Liu 56
Testing effectiveness (Phase 2)Ended earlyNCT00732940
What this trial is testing

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 56
Post-approval studies (Phase 4)Looking for participantsNCT03543839
What this trial is testing

Trial of Belimumab in Early Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus
Northwell Health 30
Post-approval studies (Phase 4)Study completedNCT01597492
What this trial is testing

Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 79
Early research (Phase 1)Looking for participantsNCT04097561
What this trial is testing

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT01532310
What this trial is testing

Belimumab (BENLYSTA®) Pregnancy Registry

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 77
Not applicableActive Not RecruitingNCT07053137
What this trial is testing

A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

Who this might be right for
Systemic Lupus ErythematosusTelitaciceptBelimumab+1 more
Yipeng Liu 180
Testing effectiveness (Phase 2)Looking for participantsNCT07539857
What this trial is testing

Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized

Who this might be right for
Kidney Transplant Rejection
Leiden University Medical Center 25
Large-scale testing (Phase 3)Study completedNCT01345253
What this trial is testing

GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 709
Large-scale testing (Phase 3)Study completedNCT01663623
What this trial is testing

Belimumab in Remission of VASculitis

Who this might be right for
Vasculitis
Human Genome Sciences Inc., a GSK Company 106
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Post-approval studies (Phase 4)Looking for participantsNCT07611214
What this trial is testing

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 150
Next Page